Interferon-Alpha Induces Psoriatic Inflammation in Mice by Phosphorylating FOXO3

• Published in: Journal of interferon & cytokine research
• Main Authors: Gu, Hanjiang, Wang, Xiaoyu, Lu, Mei, Wang, Yaqi, Ren, Kaixuan, Zhang, Yitian, Liu, Wei, Hu, Guanglei, Zeng, Weihui, Xia, Yumin
• Format: Journal Article
• Language: English
• Published: United States 01.06.2024
• Subjects: interferon-alpha; FOXO3; psoriasis; imiquimod
• ISSN: 1557-7465
• DOI: 10.1089/jir.2023.0225

Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by epidermal thickening and inflammatory cell infiltration. Excessive proliferation of keratinocytes and resistance to apoptosis lead to thickening of the epidermis. Plasmacytoid dendritic cells are involved in the occurrence of psoriasis mainly by secreting interferon-alpha (IFN-α). IFN-α is a glycoprotein with antiviral, antitumor, and immunomodulatory effects, but its role in psoriasis remains unclear. In this investigation, a mild psoriatic phenotype was observed in mice upon topical application of IFN-α cream, and the inflammation was exacerbated when combined with imiquimod (IMQ). Immunohistochemical analyses demonstrated that IFN-α induces psoriatic inflammation in mice by stimulating phosphorylation of forkhead box O3, consistent with the involvement of this protein in cell proliferation, apoptosis, and inflammation. Our results suggested that topical IFN-α caused psoriatic inflammation and that the psoriatic inflammation was exacerbated by the combination of IFN-α and IMQ, possibly due to the dysfunction of forkhead box O3.